Review
Published on 18 Oct 2024
NF-ÎşB signaling pathway in tumor microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1476030
- 741 views
Type at least 3 characters
6,669 articles
Articles
Original Research
Published on 18 Oct 2024
NSG2: a promising prognostic marker shaping the immune landscape of breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1487447
- 757 views
Systematic Review
Published on 18 Oct 2024
Analyzing research trends in glioblastoma metabolism: a bibliometric review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1444305
- 732 views
Original Research
Published on 18 Oct 2024
Tertiary lymphoid structure-related score as a predictor for survival prognosis and immunotherapy response in head and neck squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1483497
- 838 views
Systematic Review
Published on 18 Oct 2024
Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1482746
- 582 views
Original Research
Published on 18 Oct 2024
Single-cell analysis of matrisome-related genes in breast invasive carcinoma: new avenues for molecular subtyping and risk estimation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1466762
- 739 views
Original Research
Accepted on 17 Oct 2024
Immune-checkpoint HLA-G gene polymorphisms, 3'-UTR types and their association with hepatocellular carcinoma and treatment response in Indian population
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1459749
Editorial
Published on 17 Oct 2024
Editorial: Role of extracellular vesicles in promoting cancer stem cell properties, tumor aggressiveness and metastasis formation in solid tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1504676
- 372 views
Original Research
Published on 17 Oct 2024
A novel hollow iron nanoparticle system loading PEG-Fe3O4 with C5a receptor antagonist for breast cancer treatment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1466180
- 666 views
Original Research
Published on 17 Oct 2024
In silico and pharmacological evaluation of GPR65 as a cancer immunotherapy target regulating T-cell functions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1483258
- 1,505 views
Editorial
Published on 17 Oct 2024
Editorial: Immunotherapy in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1501760
- 430 views
Original Research
Published on 17 Oct 2024
mRNA-seq-based analysis predicts: AEG-1 is a therapeutic target and immunotherapy biomarker for pan-cancer, including OSCC
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1484226
- 679 views
Original Research
Published on 17 Oct 2024
Heterogeneity in peripheral blood immune lymphocyte subsets predicts the response of immunotherapy or chemoradiotherapy in advanced lung cancer: an analysis across different pathological types, treatment modalities and age
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1464728
- 592 views
Review
Published on 17 Oct 2024
Advancements in mitochondrial-targeted nanotherapeutics: overcoming biological obstacles and optimizing drug delivery
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1451989
- 638 views
Original Research
Published on 16 Oct 2024
Fatty acid metabolism prognostic signature predicts tumor immune microenvironment and immunotherapy, and identifies tumorigenic role of MOGAT2 in lung adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1456719
- 1,295 views
Editorial
Published on 16 Oct 2024
Editorial: Immunobiology and immunotherapeutics in myelodysplastic syndrome and acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1500864
- 310 views